Andrew Conrad, Verily CEO
Verily hooks $1B round amid C-suite shuffle
Verily, Alphabet’s rather secretive life sciences outfit, is riding a $1 billion cash infusion to its “next phase of growth” — and that necessitates a C …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.